Procter & Gamble (PG) Offering Possible 15.47% Return Over the Next 15 Calendar Days

Procter & Gamble's most recent trend suggests a bullish bias. One trading opportunity on Procter & Gamble is a Bull Put Spread using a strike $133.00 short put and a strike $128.00 long put offers a potential 15.47% return on risk over the next 15 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $133.00 by expiration. The full premium credit of $0.67 would be kept by the premium seller. The risk of $4.33 would be incurred if the stock dropped below the $128.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Procter & Gamble is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Procter & Gamble is bullish.

The RSI indicator is at 46.29 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Procter & Gamble

Jessica  Alba’s Honest Co., Investors Raise $413 Million in IPO
Wed, 05 May 2021 02:32:40 +0000
(Bloomberg) — The Honest Co., the personal care brand co-founded by actress Jessica Alba, raised $413 million in an initial public offering priced within a marketed range.The company and its shareholders on Tuesday sold about 25.8 million shares for $16 each, according to a statement confirming an earlier Bloomberg News report. The shares had been marketed for $14 to $17, with the company offering 6.5 million shares and existing investors selling 19.4 million.The company has a market value at the IPO price of about $1.45 billion based on the outstanding shares listed in its filings with the U.S. Securities and Exchange Commission. Fully diluted to include employee stock options and restricted stock units, that value rises to more than $1.7 billion.Founded in 2011, Honest has grown into a national brand and has partnerships with retail giants including Target Corp. and Amazon.com Inc. The Los Angeles-based company specializes in baby products such as diapers and wipes, which accounted for 63% of last year’s sales, as well as household cleaning supplies and personal care items.Now the company’s chief creative officer, Alba owns 5.65 million shares. She didn’t plan to sell her shares in the offering, according to the filings. The share sale gives her a stake valued at about $90 million.Investors selling some of their shares in the IPO included private equity firm L Catterton, Institutional Venture Partners, Lightspeed Venture Partners and General Catalyst, the filings show.Childhood AilmentsAlba has said she sought to find products with fewer harsh chemicals following childhood struggles with allergies and asthma. She became particularly concerned about ingredients in baby products and said in a recent filing that she tried to appeal to lawmakers for chemical legislation reform.Honest’s business touches on several trends that have become more prominent during the coronavirus pandemic, including a focus on wellness and elevated demand for cleaning products. Those have buoyed top-line results for household-goods companies such as Procter & Gamble Co., the maker of Pampers diapers and Tide laundry detergent.Los Angeles-based Honest generated sales last year of about $301 million, a 28% increase over 2019. It lost $14.5 million in 2020.Boom FadingAlready, though, the pandemic boom for consumer-products makers is starting to fade. P&G has acknowledged that rising costs are pressuring results, toilet paper maker Kimberly-Clark Corp. recently cut its earnings forecast and Clorox Co. last week missed Wall Street’s estimates for quarterly sales. In addition to shifting demand, manufacturers are grappling with higher commodity and freight costs.Honest said in the filing that it’s working to manage disruptions to its supply chain, but it anticipates “sustained market turmoil” as a result of the pandemic and its economic impact. “If the disruptions caused by the Covid-19 pandemic continue for an extended period of time, our ability to meet the demands of our consumers may be materially impacted.”The offering is being led by Morgan Stanley, JPMorgan Chase & Co. and Jefferies Financial Group Inc. The shares are expected to begin trading Wednesday on the Nasdaq Global Select Market under the symbol HNST.(Updates with statement in second paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

P&G Encourages Women To Talk About Imposter Syndrome in #RealDeal campaign with Lazada
Wed, 05 May 2021 02:00:00 +0000
Procter & Gamble (NYSE:PG), a leading fast-moving consumer goods company launches a new #RealDeal campaign with Lazada, Southeast Asia's leading e-commerce platform to raise awareness around Imposter syndrome.

Warren Buffett is right, inflation is running rampant
Tue, 04 May 2021 10:53:40 +0000
Inflation is picking up in a major way, C-suites across the country warn.

P&G launches iLab 2021 in partnership with the Singapore EDB to strengthen Singapore's innovation ecosystem
Tue, 04 May 2021 10:06:00 +0000
Procter & Gamble (NYSE:PG), in partnership with the Singapore Economic Development Board (EDB), today launched iLab 2021, a 3-day virtual innovation festival. The festival will see start-ups from Singapore and across the region come together to collaborate with P&G and develop innovations that can overcome real-world challenges faced in the areas of advertising, retail, and supply chain.

10 Best Consumer Staples Stocks to Buy Now
Mon, 03 May 2021 21:32:13 +0000
In this article, we will take a look at the 10 best consumer staples stocks to buy now. You can skip our comprehensive analysis of the consumer staples industry and go directly to the 5 Best Consumer Staples Stocks to Buy Now. The toilet paper shortages at the beginning of the COVID-19 pandemic drove a […]

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.